share_log

赛伦生物:关于收到实际控制人之一、董事长2024年度中期分红提议暨落实“提质增效重回报”行动方案的公告

Shanghai Serum Bio-Technology: Announcement regarding the proposal for interim dividends in 2024 by one of the actual controlling shareholders and chairman, and the implementation of the "improving quality and efficiency, and returning value" action plan.

SZSI ·  Jul 17, 2024 00:00
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more